Depleting ovarian cancer stem cells with calcitriol
Open Access
- 16 February 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (18) , 14481-14491
Abstract
Depleting ovarian cancer stem cells with calcitriol Depleting ovarian cancer stem cells with calcitriolKeywords
This publication has 46 references indexed in Scilit:
- Interleukin-1α Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem CellsCancer Research, 2011
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient SurvivalCancer Research, 2011
- A Novel Gemini Vitamin D Analog Represses the Expression of a Stem Cell Marker CD44 in Breast CancerMolecular Pharmacology, 2011
- Decreased expression of insulin‐like growth factor binding protein‐5 during N‐(4‐hydroxyphenyl)retinamide‐induced neuronal differentiation of ARPE‐19 human retinal pigment epithelial cells: Regulation by CCAAT/enhancer‐binding proteinJournal of Cellular Physiology, 2010
- Vitamin D and differentiation in cancerCritical Reviews in Clinical Laboratory Sciences, 2009
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancerNature Chemical Biology, 2009
- Vitamin D signalling pathways in cancer: potential for anticancer therapeuticsNature Reviews Cancer, 2007
- Vitamin D receptor is essential for normal keratinocyte stem cell functionProceedings of the National Academy of Sciences, 2007
- The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cellsNature Genetics, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005